Answers are grounded in this paper and cite their sources.
Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: